EP Patent

EP3831382A1 — Administration regime for nitrocatechols

Assigned to Bial Portela and Cia SA · Expires 2021-06-09 · 5y expired

What this patent protects

A compound of formula (I)where R<sub>1</sub>, R<sub>2</sub>, X, Y, n, m, R<sub>3</sub>, R<sub>4</sub>, R<sub>5</sub>, R<sub>6</sub> and R<sub>7</sub> are as defined herein, for use in the prophyla…

USPTO Abstract

A compound of formula (I)where R<sub>1</sub>, R<sub>2</sub>, X, Y, n, m, R<sub>3</sub>, R<sub>4</sub>, R<sub>5</sub>, R<sub>6</sub> and R<sub>7</sub> are as defined herein, for use in the prophylaxis or treatment of a central and peripheral nervous system disorder, wherein the compound of formula (I) is administered at bedtime.

Drugs covered by this patent

Patent Metadata

Patent number
EP3831382A1
Jurisdiction
EP
Classification
—
Expires
2021-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Bial Portela and Cia SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.